Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

88.39
Delayed Data
As of Feb 12
 +4.95 / +5.93%
Today’s Change
69.33
Today|||52-Week Range
263.81
-13.04%
Year-to-Date

Stock Price Forecast

The 21 analysts offering 12-month price forecasts for Valeant Pharmaceuticals have a median target of 155.00, with a high estimate of 213.00 and a low estimate of 90.00. The median estimate represents a +75.36% increase from the last price of 88.39.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Buy stock in Valeant Pharmaceuticals. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.60
Sales
$2.8B
Reporting Date
Feb 25

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -5.01%
 
 
 
 
 
 
Growthannually 23.07%
 
 
 
 
 
 

Sales

Growthquarterly -0.31%
 
 
 
 
 
 
Growthannually 26.86%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.